Endoscopic therapeutic esophageal interventions: Something old, something new, something to be established

Current Opinion in Gastroenterology

Volumn 20, Issue 4, 2004, Pages 397-403

  Siersema, Peter D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Achalasia; Barrett esophagus; Endoscopic antireflux procedure; Esophageal cancer; Self expanding stent; Stricture; Variceal bleeding

Indexed keywords

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; BENIGN TUMOR; CANCER PALLIATIVE THERAPY; ENDOSCOPIC SURGERY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS CARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS EXAMINATION; ESOPHAGUS MUCOSA; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; ESOPHAGUS TUMOR; ESOPHAGUS VARICES BLEEDING; GASTROESOPHAGEAL REFLUX; HUMAN; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; REVIEW; STENT; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 3042638511     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200407000-00017     Document Type: Review

References (37)

1. Litle VR, Luketich JD, Christie NA, et al.: Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. Ann Thorac Surg 2003, 76:1687-1692; discussion 1692-1693.
2. Overholt BF, Panjehpour M, Halberg DL: Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc 2003, 58:183-188. Follow-up study of large cohort of patients with Barrett esophagus, showing that PDT may reduce the expected frequency of carcinoma in Barrett dysplasia.
3. Krishnadath KK, Wang KK, Taniguchi K, et al.: Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy. Gastroenterology 2000, 119:624-630.
4. van Hillegersberg R, Haringsma J, ten Kate FJW, et al.: Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus. Dig Surg 2003, 20:440-444.
5. Sampliner RE: Endoscopic ablative therapy for Barrett's esophagus: current status. Gastrointest Endosc 2004, 59:66-69. This is an interesting editorial on the state of the art of ablative therapy for Barrett esophagus.
6. Ackroyd R, Kelty CJ, Brown NJ, et al.: Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy 2003, 35:496-501.
7. Hur C, Nishioka NS, Gazelle GS: Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci 2003, 48:1273-1283.
8. May A, Gossner L, Behrens A, et al.: A prospective randomized trial of two different endoscopic resection techniques for early stage cancer of the esophagus. Gastrointest Endosc 2003, 58:167-175. Randomized trial showing that the cap technique and the ligation technique for endoscopic mucosal resection are similar with respect to efficacy and safety.
9. Feitoza AB, Gostout CJ, Burgart LJ, et al.: Hydroxypropyl methylcellulose: a better submucosal fluid cushion for endoscopic mucosal resection. Gastrointest Endosc 2003, 57:41-47. Interesting experimental study showing that hydroxypropyl methylcellulose is a low-cost option for creating submucosal fluid cushions for endoscopic mucosal resections.
10. Kuwano H, Mochiki E, Asao T, et al.: Double endoscopic intraluminal operation for upper digestive tract diseases: proposal of a novel procedure. Ann Surg 2004, 239:22-27.
11. Seewald S, Akaraviputh T, Seitz U, et al.: Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc 2003, 57:854-859. Important study showing that circumferential endoscopic mucosal resection is feasible, safe, and effective for complete removal of Barrett epithelium.
12. Satodate H, Inoue H, Yoshida T, et al.: Circumferential EMR of carcinoma arising in Barrett's esophagus: case report. Gastrointest Endosc 2003, 58:288-291.
13. Katada C, Muto M, Manabe T, et al.: Esophageal stenosis after endoscopic mucosal resection of superficial esophageal lesions. Gastrointest Endosc 2003, 57:165-169.
14. Said A, Brust DJ, Gaumnitz EA, et al.: Predictors of early recurrence of benign esophageal strictures. Am J Gastroenterol 2003, 98:1252-1256.
15. Schubert D, Kuhn R, Lippert H, et al.: Endoscopic treatment of benign gastrointestinal anastomotic strictures using argon plasma coagulation in combination with diathermy. Surg Endosc 2003, 17:1579-1582. Study showing that benign anastomotic strictures can be treated with a combination of argon plasma coagulation and diathermy as an alternative to dilation.
16. Mayoral W, Fleischer D, Calcedo J, et al.: Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest Endosc 2000, 51:556-559.
17. Dormann AJ, Eisendrath P, Wigginghaus B, et al.: Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 2003, 35:207-211. Interesting study showing that plastic Polyflex stents are effective in palliating malignant dysphagia and in reducing the rate of recurrent dysphagia from nontumoral ingrowth or overgrowth.
18. Costamagna G, Shah SK, Tringali A, et al.: Prospective evaluation of a new self-expanding plastic stent for inoperable esophageal strictures. Surg Endosc 2003, 17:891-895.
19. Siersema PD, Homs MY, Haringsma J, et al.: Use of large-diameter metallic stents to seal traumatic nonmalignant perforations of the esophagus. Gastrointest Endosc 2003, 58:356-361. Study showing that nonmalignant perforations of the esophagus can be treated with covered self-expanding metal stents.
20. Petruzziello L, Tringali A, Riccioni ME, et al.: Successful early treatment of Boerhaave's syndrome by endoscopic placement of a temporary self-expanding plastic stent without fiuoroscopy. Gastrointest Endosc 2003, 58:608-612.
21. Wadhwa RP, Kozarek RA, France RE, et al.: Use of self-expandable metallic stents in benign GI diseases. Gastrointest Endosc 2003, 58:207-212.
22. Low DE, Kozarek RA: Removal of esophageal expandable metal stents: description of technique and review of potential applications. Surg Endosc 2003, 17:990-996.
23. Alonso-Aguirre P, Aba-Garrote C, Estevez-Prieto E, et al.: Treatment of achalasia with the Witzel dilator: a prospective randomized study of two methods. Endoscopy 2003, 35:379-382.
24. Bansal R, Nostrant TT, Scheiman JM, et al.: Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia. J Clin Gastroenterol 2003, 36:209-214.
25. Richardson WS, Willis GW, Smith JW: Evaluation of scar formation after botulinum toxin injection or forced balloon dilation to the lower esophageal sphincter. Surg Endosc 2003, 17:696-698.
26. Cheng YS, Li MH, Chen WX, et al.: Selection and evaluation of three interventional procedures for achalasia based on long-term follow-up. World J Gastroenterol 2003, 9:2370-2373. Important study showing that temporarily placed covered metal stents can be used to treat achalasia.
27. Sorbi D, Gostout CJ, Peura D, et al.: An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am J Gastroenterol 2003, 98:2424-2434.
28. D'Amico G, Pietrosi G, Tarantino I, et al.: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003, 124:1277-1291. Meta-analysis not supporting emergency sclerotherapy as the first-line treatment of variceal bleeding in cirrhosis compared with vasoactive drugs.
29. Feitoza AB, Gostout CJ, Rajan E, et al.: Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications. Gastrointest Endosc 2003, 57:868-876. Experimental study investigating the histopathologic response to endoluminal gastroplications in rabbit stomach. This study questions the long-term effectiveness of gastroplications.
30. Pleskow D, Rothstein R, Lo S, et al.: Endoscopic full-thickness plication for the treatment of GERD: a multicenter trial. Gastrointest Endosc 2004, 59:163-171.
31. Mahmood Z, McMahon BP, Arfin Q, et al.: Endocinch therapy for gastrooesophageal reflux disease: a one year prospective follow up. Gut 2003, 52:34-39.
32. Kim MS, Holloway RH, Dent J, et al.: Radiofrequency energy delivery to the gastric cardia inhibits triggering of transient lower esophageal sphincter relaxation and gastroesophageal reflux in dogs. Gastrointest Endosc 2003, 57:17-22.
33. Tam WCE, Schoeman MN, Zhang Q, et al.: Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut 2003, 52:479-485.
34. Corley DA, Katz P, Wo JM, et al.: Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology 2003, 125:668-676. Important placebo-controlled study showing that radiofrequency energy improves gastroesophageal reflux symptoms and quality of life but has no effect on esophageal acid exposure or medication use.
35. Harewood GC, Gostout CJ: Cost analysis of endoscopic antireflux procedures: endoluminal plication vs. radiofrequency coagulation vs. treatment with a proton pump inhibitor. Gastrointest Endosc 2003, 58:493-499.
36. Johnson DA, Ganz R, Aisenberg J, et al.: Endoscopic, deep mural implantation of Enteryx for the treatment of GERD: 6-month follow-up of a multicenter trial. Am J Gastroenterol 2003, 98:250-258.
37. Johnson DA, Ganz R, Aisenberg J, et al.: Endoscopic implantation of Enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol 2003, 98:1921-1930.